Bile Bacterial Colonization Increases Risk of Postoperative Pancreatic Fistula and Worsens Overall Survival Following Pancreatoduodenectomy
Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design and Eligibility Criteria
2.2. Surgical Technique
2.3. Microbiological Identification Methods
2.4. Statistical Analysis
3. Results
3.1. Baseline Characteristics of the Study Population
3.2. Bile Colonization and Postoperative Pancreatic Fistula
3.3. Association Between Bile Bacterial Colonization and Postoperative Pancreatic Fistula
3.4. Bile Colonization and Overall Survival After a PD
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| AMR | Antimicrobial Resistance |
| BRM | Bacteria with Resistance Mechanisms |
| ERCP | Endoscopic Retrograde Cholangiopancreatography |
| PBD | Preoperative Biliary Drainage |
| PC | Pancreatic Cancer |
| PD | Pancreatoduodenectomy |
| PDAC | Pancreatic Ductal Adenocarcinoma |
| POPF | Postoperative Pancreatic Fistula |
References
- Luo, W.; Wang, J.; Chen, H.; Ye, L.; Qiu, J.; Liu, Y.; Wang, R.; Weng, G.; Liu, T.; Su, D.; et al. Epidemiology of pancreatic cancer: New version, new vision. Chin. J. Cancer Res. 2023, 35, 438–450. [Google Scholar] [CrossRef] [PubMed]
- Rawla, P.; Sunkara, T.; Gaduputi, V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J. Oncol. 2019, 10, 10–27. [Google Scholar] [CrossRef]
- Reyna-Sepúlveda, F.; Muñoz-Maldonado, G.; Pérez-Rodríguez, E.; Hernández-Trejo, F.; Guevara-Charles, A.; Hernández-Guedea, M. Prognostic factors for survival and surgical complications in Whipple’s pancreatoduodenectomy during a 10-year experience. Cir. Cir. 2019, 87, 205–210. [Google Scholar] [CrossRef] [PubMed]
- Russell, T.B.; Labib, P.L.; Denson, J.; Streeter, A.; Ausania, F.; Pando, E.; Roberts, K.J.; Kausar, A.; Mavroeidis, V.K.; Marangoni, G.; et al. Postoperative complications after pancreatoduodenectomy for malignancy: Results from the Recurrence After Whipple’s (RAW) study. BJS Open 2023, 7, zrad106. [Google Scholar] [CrossRef]
- Simon, R. Complications After Pancreaticoduodenectomy. Surg. Clin. N. Am. 2021, 101, 865–874. [Google Scholar] [CrossRef] [PubMed]
- Russell, T.B.; Aroori, S. Procedure-specific morbidity of pancreatoduodenectomy: A systematic review of incidence and risk factors. ANZ J. Surg. 2022, 92, 1347–1355. [Google Scholar] [CrossRef]
- Pedrazzoli, S. Pancreatoduodenectomy (PD) and postoperative pancreatic fistula (POPF): A systematic review and analysis of the POPF-related mortality rate in 60,739 patients retrieved from the English literature published between 1990 and 2015. Medicine 2017, 96, e6858. [Google Scholar] [CrossRef]
- Russell, T.B.; Labib, P.L.; Ausania, F.; Pando, E.; Roberts, K.J.; Kausar, A.; Mavroeidis, V.K.; Marangoni, G.; Thomasset, S.C.; Frampton, A.E.; et al. Serious complications of pancreatoduodenectomy correlate with lower rates of adjuvant chemotherapy: Results from the recurrence after Whipple’s (RAW) study. Eur. J. Surg. Oncol. 2023, 49, 106919. [Google Scholar] [CrossRef]
- Mackay, T.M.; Smits, F.J.; Roos, D.; Bonsing, B.A.; Bosscha, K.; Busch, O.R.; Creemers, G.J.; van Dam, R.M.; van Eijck, C.H.; Gerhards, M.F.; et al. The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: A nationwide analysis. HPB 2020, 22, 233–240. [Google Scholar] [CrossRef]
- Karki, S.; Kandel, B.; Sharma, D.; Koirala, N.; Lakhey, P.J. Relevance of the International Study Group of Pancreatic Surgery and the Dutch Pancreatic Cancer Group Classifications of Pancreas-Specific Risk Factors in Predicting Clinically Relevant Postoperative Pancreatic Fistula in the Whipple Procedure. Cureus 2025, 17, e84051. [Google Scholar] [CrossRef]
- Hu, B.Y.; Wan, T.; Zhang, W.Z.; Dong, J.H. Risk factors for postoperative pancreatic fistula: Analysis of 539 successive cases of pancreaticoduodenectomy. World J. Gastroenterol. 2016, 22, 7797–7805. [Google Scholar] [CrossRef]
- Müssle, B.; Hempel, S.; Kahlert, C.; Distler, M.; Weitz, J.; Welsch, T. Prognostic Impact of Bacterobilia on Morbidity and Postoperative Management After Pancreatoduodenectomy: A Systematic Review and Meta-analysis. World J. Surg. 2018, 42, 2951–2962. [Google Scholar] [CrossRef]
- Ohgi, K.; Sugiura, T.; Yamamoto, Y.; Okamura, Y.; Ito, T.; Uesaka, K. Bacterobilia may trigger the development and severity of pancreatic fistula after pancreatoduodenectomy. Surgery 2016, 160, 725–730. [Google Scholar] [CrossRef]
- Pretzsch, E.; Heim, A.; Heiliger, C.; Pretzsch, C.M.; Ilmer, M.; Weniger, M.; Renz, B.; Guba, M.; Angele, M.K.; D’Haese, J.G.; et al. Specific intraoperative antibiotic therapy abrogates the negative effect of biliary contamination on the Comprehensive Complication Index after pancreatic head resection. Surgery 2022, 171, 1642–1651. [Google Scholar] [CrossRef]
- Panni, R.Z.; Panni, U.Y.; Liu, J.; Williams, G.A.; Fields, R.C.; Sanford, D.E.; Hawkins, W.G.; Hammill, C.W. Re-defining a high volume center for pancreaticoduodenectomy. HPB 2021, 23, 733–738. [Google Scholar] [CrossRef]
- Hackert, T.; Strobel, O.; Michalski, C.W.; Mihaljevic, A.L.; Mehrabi, A.; Müller-Stich, B.; Berchtold, C.; Ulrich, A.; Büchler, M.W. The TRIANGLE operation—Radical surgery after neoadjuvant treatment for advanced pancreatic cancer: A single arm observational study. HPB 2017, 19, 1001–1007. [Google Scholar] [CrossRef] [PubMed]
- Schneider, M.; Strobel, O.; Hackert, T.; Büchler, M.W. Pancreatic resection for cancer-the Heidelberg technique. Langenbecks Arch. Surg. 2019, 404, 1017–1022. [Google Scholar] [CrossRef] [PubMed]
- Schneider, M.; Hackert, T.; Strobel, O.; Büchler, M.W. Technical advances in surgery for pancreatic cancer. Br. J. Surg. 2021, 108, 777–785. [Google Scholar] [CrossRef] [PubMed]
- Isaji, S.; Mizuno, S.; Windsor, J.A.; Bassi, C.; Fernández-del Castillo, C.; Hackert, T.; Hayasaki, A.; Katz, M.H.; Kim, S.W.; Kishiwada, M.; et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology 2018, 18, 2–11. [Google Scholar] [CrossRef]
- Bassi, C.; Marchegiani, G.; Dervenis, C.; Sarr, M.; Hilal, M.A.; Adham, M.; Allen, P.; Andersson, R.; Asbun, H.J.; Besselink, M.G.; et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery 2017, 161, 584–591. [Google Scholar] [CrossRef]
- Pande, R.; Halle-Smith, J.M.; Phelan, L.; Thorne, T.; Panikkar, M.; Hodson, J.; Roberts, K.J.; Arshad, A.; Connor, S.; Conlon, K.C.; et al. External validation of postoperative pancreatic fistula prediction scores in pancreatoduodenectomy: A systematic review and meta-analysis. HPB 2022, 24, 287–298. [Google Scholar] [CrossRef] [PubMed]
- Kamarajah, S.K.; Bundred, J.R.; Lin, A.; Halle-Smith, J.; Pande, R.; Sutcliffe, R.; Harrison, E.M.; Roberts, K.J. PARANOIA Study Group. Systematic review and meta-analysis of factors associated with post-operative pancreatic fistula following pancreatoduodenectomy. ANZ J. Surg. 2021, 91, 810–821. [Google Scholar] [CrossRef] [PubMed]
- Schuh, F.; Mihaljevic, A.L.; Probst, P.; Trudeau, M.T.; Müller, P.C.; Marchegiani, G.; Besselink, M.G.; Uzunoglu, F.; Izbicki, J.R.; Falconi, M.; et al. A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic Surgery. Ann. Surg. 2023, 277, e597–e608. [Google Scholar] [CrossRef]
- Okano, K.; Suzuki, Y. Influence of bile contamination for patients who undergo pancreaticoduodenectomy after biliary drainage. World J. Gastroenterol. 2019, 25, 6847–6856. [Google Scholar] [CrossRef]
- Filson, A.; Gaskins, J.T.; Martin, R.C.G. A meta-analysis and systematic review of intraoperative bile cultures association with postoperative complications in pancreaticoduodenectomy. Surgery 2023, 173, 1231–1239. [Google Scholar] [CrossRef]
- Shrader, H.R.; Miller, A.M.; Tomanek-Chalkley, A.; McCarthy, A.; Coleman, K.L.; Ear, P.H.; Mangalam, A.K.; Salem, A.K.; Chan, C.H. Effect of bacterial contamination in bile on pancreatic cancer cell survival. Surgery 2021, 169, 617–622. [Google Scholar] [CrossRef]
- Sethi, V.; Kurtom, S.; Tarique, M.; Lavania, S.; Malchiodi, Z.; Hellmund, L.; Zhang, L.; Sharma, U.; Giri, B.; Garg, B.; et al. Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response. Gastroenterology 2018, 155, 33–37.e6. [Google Scholar] [CrossRef] [PubMed]
- Weniger, M.; Hank, T.; Qadan, M.; Ciprani, D.; Michelakos, T.; Niess, H.; Heiliger, C.; Ilmer, M.; D’Haese, J.G.; Ferrone, C.R.; et al. Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer. Br. J. Surg. 2021, 108, 709–716. [Google Scholar] [CrossRef]
- Jiang, H.; Tian, Y.; Xu, L.; Chen, X.; Huang, Y.; Wu, J.; Wang, T.; Liu, T.; Wu, X.; Ye, C.; et al. Alterations of the bile microbiome is associated with progression-free survival in pancreatic ductal adenocarcinoma patients. BMC Microbiol. 2024, 24, 235. [Google Scholar] [CrossRef]
- de Castilhos, J.; Tillmanns, K.; Blessing, J.; Laraño, A.; Borisov, V.; Stein-Thoeringer, C.K. Microbiome and pancreatic cancer: Time to think about chemotherapy. Gut Microbes 2024, 16, 2374596. [Google Scholar] [CrossRef]
- Geller, L.T.; Barzily-Rokni, M.; Danino, T.; Jonas, O.H.; Shental, N.; Nejman, D.; Gavert, N.; Zwang, Y.; Cooper, Z.A.; Shee, K.; et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 2017, 357, 1156–1160. [Google Scholar] [CrossRef]
- Pushalkar, S.; Hundeyin, M.; Daley, D.; Zambirinis, C.P.; Kurz, E.; Mishra, A.; Mohan, N.; Aykut, B.; Usyk, M.; Torres, L.E.; et al. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov. 2018, 8, 403–416. [Google Scholar] [CrossRef]
- Krüger, C.M.; Adam, U.; Adam, T.; Kramer, A.; Heidecke, C.D.; Makowiec, F.; Riediger, H. Bacterobilia in pancreatic surgery-conclusions for perioperative antibiotic prophylaxis. World J. Gastroenterol. 2019, 25, 6238–6247. [Google Scholar] [CrossRef] [PubMed]
- Sourrouille, I.; Gaujoux, S.; Lacave, G.; Bert, F.; Dokmak, S.; Belghiti, J.; Paugam-Burtz, C.; Sauvanet, A. Five days of postoperative antimicrobial therapy decreases infectious complications following pancreaticoduodenectomy in patients at risk for bile contamination. HPB 2013, 15, 473–480. [Google Scholar] [CrossRef]
- Stein-Thoeringer, C.K.; Renz, B.W.; De Castilhos, J.; von Ehrlich-Treuenstätt, V.; Wirth, U.; Tschaidse, T.; Hofmann, F.O.; Koch, D.T.; Beirith, I.; Ormanns, S.; et al. Microbiome Dysbiosis With Enterococcus Presence in the Upper Gastrointestinal Tract Is a Risk Factor for Mortality in Patients Undergoing Surgery for Pancreatic Cancer. Ann. Surg. 2025, 281, 615–623. [Google Scholar] [CrossRef] [PubMed]
- Hoffmann, M.; Anthuber, L.; Anthuber, M.; Pinto, D.; Schrempf, M. Positive Intraoperative Bile Culture and Antibiotic Resistance Increase the Risk of Pancreatic Fistula in Patients After Pancreatoduodenectomy. J. Clin. Med. 2025, 14, 455. [Google Scholar] [CrossRef] [PubMed]
- Olszewska, N.; Guzel, T.; Milner, A.; Paluszkiewicz, P.; Podsiadły, E.; Słodkowski, M. Should Preoperative Biliary Decontamination Be Considered to Minimize Morbidity and Mortality Following Pancreatoduodenectomy? Antibiotics 2026, 15, 134. [Google Scholar] [CrossRef]



| Variable | Mean ± SD/Total (n = 138) (%) | Range or Categories |
|---|---|---|
| Age (years) | 66.3 ± 9.8 | 37–89 |
| BMI (kg/m2) | 25.2 ± 4.6 | 16.4–42.2 |
| Male sex | 72 (52.2%) | Male/Female |
| Preoperative diabetes mellitus | 34 (24.6%) | |
| American Society of Anesthesiologists (ASA) classification: | ||
| I II III | 18 (13.1%) 87 (63.0%) 33 (23.9%) | |
| Preoperative Endoscopic Retrograde Cholangiopancreatography (ERCP) | 101 (73.2%) | |
| Positive bile culture (Bacteriobilia) | 106 (76.8%) | |
| Positive bile culture in patients after preoperative ERCP | 94 (93.1% a) | |
| Bacteria with resistance mechanisms (BRM) | 17 (12.3%) | |
| POPF clinically relevant: | 24 (17.4%) | |
| POPF grade B | 16 (11.6%) | |
| POPF grade C | 8 (5.8%) |
| Bacterial Species | Resistance Mechanism | Total (n = 23) (%) |
|---|---|---|
| Enterococcus casseliflavus | VRE | 2 (8.7%) |
| Enterococcus gallinarum | VRE | 1 (4.3%) |
| Klebsiella pneumoniae | ESBL + NDM | 3 (13.0%) |
| Klebsiella pneumoniae | ESBL | 7 (30.4%) |
| Klebsiella oxytoca | ESBL | 1 (4.3%) |
| Escherichia coli | ESBL | 7 (30.4%) |
| Enterobacter aerogenes | ESBL | 1 (4.3%) |
| Enterobacter cloacae | ESBL | 1 (4.3%) |
| POPF Grade B | ||
|---|---|---|
| Bacteria status: | OR with 95% CI | p-value |
| negative | 1.00 | |
| positive | 5.11 (0.65–40.30) | 0.088 |
| Bacteria resistance: | ||
| no BRM | 1.00 | |
| BRM | 1.02 (0.21–4.93) | 0.981 |
| POPF Grade C | ||
| Bacteria status: | OR with 95% CI | p-value |
| negative | 1.00 | |
| positive | 0.48 (0.11–2.12) | 0.323 |
| Bacteria resistance: | ||
| no BRM | 1.00 | |
| BRM | OR 4.97 (1.071–23.07) | 0.026 * |
| POPF Grade B | POPF Grade C | POPF Clinically Relevant | |
|---|---|---|---|
| Bacteriobilia | OR 8.04 (0.98–66.18); p = 0.048 * | OR 1.61 (0.16–16.48); p = 0.686 | OR 5.50 (1.14–26.6); p = 0.034 * |
| BRM | OR 0.63 (0.12–3.33); p = 0.590 | OR 6.17 (1.02–45.61); p = 0.047 * | OR 1.66 (0.45–6.02); p = 0.444 |
| Age | OR 0.997 (0.95–1.05); p = 0.942 | OR 0.95 (0.87–1.05); p = 0.316 | OR 0.985 (0.94–1.04); p = 0.558 |
| Sex (male) | OR 1.58 (0.53–4.71); p = 0.417 | OR 1.67 (0.29–10.02); p = 0.560 | OR 1.72 (0.65–4.56); p = 0.278 |
| BMI | OR 1.05 (0.94–1.17); p = 0.378 | OR 1.05 (0.90–1.23); p = 0.525 | OR 1.06 (0.96–1.17); p = 0.257 |
| ASA | OR 0.39 (0.11–1.41); p = 0.151 | OR 0.55 (0.09–3.32); p = 0.515 | OR 0.37 (0.12–1.15); p = 0.087 |
| Pancreatic anastomosis technique (duct to mucosa) | OR 0.94 (0.25–3.46); p = 0.921 | OR 0.59 (0.12–3.07); p = 0.533 | OR 0.75 (0.25–2.29); p = 0.619 |
| Variable | HR (95% CI) | p-Value |
|---|---|---|
| Positive culture | 1.95 (1.12–3.41) | 0.019 * |
| Staging | 2.29 (1.40–3.75) | 0.001 * |
| Positive culture × Staging (interaction) | 0.60 (0.15–2.37) | 0.463 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Olszewska, N.; Guzel, T.; Śmigielska, K.; Paluszkiewicz, P.; Milner, A.; Podsiadły, E.; Słodkowski, M. Bile Bacterial Colonization Increases Risk of Postoperative Pancreatic Fistula and Worsens Overall Survival Following Pancreatoduodenectomy. J. Clin. Med. 2026, 15, 1566. https://doi.org/10.3390/jcm15041566
Olszewska N, Guzel T, Śmigielska K, Paluszkiewicz P, Milner A, Podsiadły E, Słodkowski M. Bile Bacterial Colonization Increases Risk of Postoperative Pancreatic Fistula and Worsens Overall Survival Following Pancreatoduodenectomy. Journal of Clinical Medicine. 2026; 15(4):1566. https://doi.org/10.3390/jcm15041566
Chicago/Turabian StyleOlszewska, Natalia, Tomasz Guzel, Kaja Śmigielska, Piotr Paluszkiewicz, Agnieszka Milner, Edyta Podsiadły, and Maciej Słodkowski. 2026. "Bile Bacterial Colonization Increases Risk of Postoperative Pancreatic Fistula and Worsens Overall Survival Following Pancreatoduodenectomy" Journal of Clinical Medicine 15, no. 4: 1566. https://doi.org/10.3390/jcm15041566
APA StyleOlszewska, N., Guzel, T., Śmigielska, K., Paluszkiewicz, P., Milner, A., Podsiadły, E., & Słodkowski, M. (2026). Bile Bacterial Colonization Increases Risk of Postoperative Pancreatic Fistula and Worsens Overall Survival Following Pancreatoduodenectomy. Journal of Clinical Medicine, 15(4), 1566. https://doi.org/10.3390/jcm15041566

